Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Digital roundup

Genzyme, Merck, the forthcoming EU clinical trials portal and more

Digital pharmaIn this digital roundup we look at the EMA's clinical trials portal, the chief digital officer role, Merck's popular periodic table app and more.

Just 6% of pharmaceutical companies currently employs a chief digital officer, according to a new report. The 2015 Chief Digital Officer Study did find that their the numbers of this executive position were growing and - perhaps unsurprisingly - larger companies tended to be ahead of the curse with this trend.

The EMA will launch its new clinical trials portal and database in October 2017 as part of its commitments under the 2014 European Clinical Trial Regulation. The service will allow for the submission, authorisation and supervision of trials in the EU and serve as an information source for the public.

Sanofi's specialty care business Genzyme has been rebranded as Sanofi Genzyme, and the unit took the opportunity to join Facebook. Its presence on the social network adds to the firm's use of YouTube, LinkedIn and Twitter.

Merck has updated its periodic table of the elements mobile app. The previous version of its free PTE app racked up more than one million downloads and the new version, again aimed at a audience that encompasses school students or professors, laypeople or professional technicians, looks to provide a greater depth of information and improved usability.

5th February 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics